首页 > 最新文献

Indian Journal of Palliative Care最新文献

英文 中文
Oral Presentation: Awardees 口头报告:获奖者
IF 1.1 Q3 Medicine Pub Date : 2023-05-30 DOI: 10.25259/ijpc_29_2_150
{"title":"Oral Presentation: Awardees","authors":"","doi":"10.25259/ijpc_29_2_150","DOIUrl":"https://doi.org/10.25259/ijpc_29_2_150","url":null,"abstract":"","PeriodicalId":13319,"journal":{"name":"Indian Journal of Palliative Care","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2023-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49201191","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Poster Presentation: Awardees 海报展示:得奖者
IF 1.1 Q3 Medicine Pub Date : 2023-05-30 DOI: 10.25259/ijpc_29_2_103
{"title":"Poster Presentation: Awardees","authors":"","doi":"10.25259/ijpc_29_2_103","DOIUrl":"https://doi.org/10.25259/ijpc_29_2_103","url":null,"abstract":"","PeriodicalId":13319,"journal":{"name":"Indian Journal of Palliative Care","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2023-05-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48530575","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Life before Death in India: A Narrative Review. 《印度死前的生活:叙事评论》。
IF 1.1 Q3 Medicine Pub Date : 2023-04-01 Epub Date: 2023-01-11 DOI: 10.25259/IJPC_44_2022
Wasey Ali Yadullahi Mir, Sudha Misra, Devang Sanghavi

Palliative care is an ever-increasing need in India, with its large population and rising burden of chronic illness. India ranks 67th out of 80 countries in the quality of death index, which measures the availability and quality of palliative care. Community-led projects in Kerala have proven successful in improving palliative care access with modest resources and volunteer involvement. In India, the number of hospice facilities is increasing; however, <1% of the Indian population has access to palliative care. Financial and human resources limitations in the health-care system, poverty and high health-care expenditure, the lack of awareness among the public about end-of-life care, hesitance to seek care due to social stigma, strict laws regarding opiates that hinder adequate pain relief and the apparent conflict between traditional social values and western values regarding death are the major obstacles to improving palliative care. Significant efforts focused on public awareness of end-of-life care and locally-tailored programmes with family and community involvement are necessary to address this issue and integrate palliative care into the primary care system. Furthermore, we discuss the effects of the COVID-19 pandemic that has been managed effectively by palliative care involvement.

印度人口众多,慢性病负担不断加重,对姑息治疗的需求日益增加。印度的死亡质量指数在80个国家中排名第67位,该指数衡量姑息治疗的可用性和质量。事实证明,喀拉拉邦由社区主导的项目通过适度的资源和志愿者参与,在改善姑息治疗方面取得了成功。在印度,临终关怀机构的数量正在增加;然而
{"title":"Life before Death in India: A Narrative Review.","authors":"Wasey Ali Yadullahi Mir,&nbsp;Sudha Misra,&nbsp;Devang Sanghavi","doi":"10.25259/IJPC_44_2022","DOIUrl":"10.25259/IJPC_44_2022","url":null,"abstract":"<p><p>Palliative care is an ever-increasing need in India, with its large population and rising burden of chronic illness. India ranks 67<sup>th</sup> out of 80 countries in the quality of death index, which measures the availability and quality of palliative care. Community-led projects in Kerala have proven successful in improving palliative care access with modest resources and volunteer involvement. In India, the number of hospice facilities is increasing; however, <1% of the Indian population has access to palliative care. Financial and human resources limitations in the health-care system, poverty and high health-care expenditure, the lack of awareness among the public about end-of-life care, hesitance to seek care due to social stigma, strict laws regarding opiates that hinder adequate pain relief and the apparent conflict between traditional social values and western values regarding death are the major obstacles to improving palliative care. Significant efforts focused on public awareness of end-of-life care and locally-tailored programmes with family and community involvement are necessary to address this issue and integrate palliative care into the primary care system. Furthermore, we discuss the effects of the COVID-19 pandemic that has been managed effectively by palliative care involvement.</p>","PeriodicalId":13319,"journal":{"name":"Indian Journal of Palliative Care","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/60/29/IJPC-29-207.PMC10261930.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9648152","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oral Methadone versus Morphine IR for Patients with Cervical Cancer and Neuropathic Pain: A Prospective Randomised Controlled Trial. 宫颈癌症和神经性疼痛患者口服美沙酮与吗啡IR的前瞻性随机对照试验。
IF 1.1 Q3 Medicine Pub Date : 2023-04-01 Epub Date: 2023-05-30 DOI: 10.25259/IJPC_58_2022
Aruna Adumala, Gayatri Palat, Archana Vajjala, Eva Brun, Mikael Segerlantz

Objectives: In India, cervical cancer is the most common cancer among women and makes up for up to 29% of all registered cancer in females. Cancer-related pain is one of the major distressing symptoms for all cancer patients. Pain is characterised as somatic or neuropathic, and the total pain experience is often mixed. Conventional opioids are the backbone of analgesic treatment but are most often not sufficient in alleviating neuropathic pain, common in cervical cancer. Accumulating evidence of the advantage of methadone compared to conventional opioids, due to agonist action at both μ and q opioid receptors, N-methyl-D-aspartate (NMDA) antagonist activity and the ability to inhibit the reuptake of monoamines has been demonstrated. We hypothesised that, with these properties', methadone might be a good option for the treatment of neuropathic pain in patients with cervical cancer.

Material and methods: Patients with cervical cancer stages ll-lll were enrolled in this randomized controlled trial. A comparison was made between methadone versus immediate release morphine (IR morphine), with increasing doses until pain was controlled. Inclusion-period was from October 3rd to December 31st 2020, and the total patient-study period was 12 weeks. Pain intensity was assessed according to the Numeric Rating Scale (NRS) and Douleur Neuropathique (DN4). The primary objective was to determine whether methadone was clinically superior versus noninferior to morphine as an analgesic for the treatment of cancer related neuropathic pain in women with cervical cancer.

Results: A total of 85 women were included; five withdrew and six died during the study period, leaving 74 patients completing the study. All participants showed a reduction in mean values of NRS and DN4 from the time of inclusion and to the end of the study period, for IR morphine and methadone 8.4-2.7 and 8.6-1.5, respectively (P < 0.001). The DN4 score mean reduction for Morphine and Methadone were 6.12-1.37 and 6.05-0, respectively (P < 0.001). Side effects were more common in the group of patients receiving IR morphine compared to the patients treated with methadone.

Conclusion: We found that Methadone had a superior analgesic effect with good overall tolerability compared with morphine as a first-line strong opioid for the management of cancer-related neuropathic pain.

目的:在印度,宫颈癌症是女性中最常见的癌症,占女性癌症登记总数的29%。癌症相关疼痛是所有癌症患者的主要痛苦症状之一。疼痛的特征是躯体或神经性的,总的疼痛体验往往是混合的。常规阿片类药物是镇痛治疗的支柱,但通常不足以缓解神经性疼痛,神经性疼痛在癌症中很常见。由于对μ和q阿片受体的激动剂作用、N-甲基-D-天冬氨酸(NMDA)拮抗剂活性和抑制单胺再摄取的能力,美沙酮与传统阿片类药物相比具有优势的证据越来越多。我们假设,有了这些特性,美沙酮可能是治疗癌症患者神经性疼痛的好选择。材料和方法:癌症ll-ll期患者被纳入本随机对照试验。将美沙酮与立即释放吗啡(IR吗啡)进行比较,增加剂量直到疼痛得到控制。纳入期为2020年10月3日至12月31日,患者总研究期为12周。根据数字评定量表(NRS)和Douler神经病(DN4)评估疼痛强度。主要目的是确定美沙酮作为治疗癌症妇女癌症相关神经性疼痛的镇痛药在临床上是否优于吗啡,而非吗啡。结果:共纳入85名女性;在研究期间,5名患者退出,6名患者死亡,剩下74名患者完成了研究。所有参与者从纳入时到研究期结束,IR吗啡和美沙酮的NRS和DN4平均值分别降低了8.4-2.7和8.6-1.5(P<0.001)。吗啡和美沙酮的DN4得分平均降低了6.12-1.37和6.05-0,与美沙酮组相比,IR吗啡组的副作用更为常见。结论:与吗啡作为一线强阿片类药物治疗癌症相关神经性疼痛相比,美沙酮具有优越的镇痛效果和良好的总体耐受性。
{"title":"Oral Methadone versus Morphine IR for Patients with Cervical Cancer and Neuropathic Pain: A Prospective Randomised Controlled Trial.","authors":"Aruna Adumala,&nbsp;Gayatri Palat,&nbsp;Archana Vajjala,&nbsp;Eva Brun,&nbsp;Mikael Segerlantz","doi":"10.25259/IJPC_58_2022","DOIUrl":"10.25259/IJPC_58_2022","url":null,"abstract":"<p><strong>Objectives: </strong>In India, cervical cancer is the most common cancer among women and makes up for up to 29% of all registered cancer in females. Cancer-related pain is one of the major distressing symptoms for all cancer patients. Pain is characterised as somatic or neuropathic, and the total pain experience is often mixed. Conventional opioids are the backbone of analgesic treatment but are most often not sufficient in alleviating neuropathic pain, common in cervical cancer. Accumulating evidence of the advantage of methadone compared to conventional opioids, due to agonist action at both μ and q opioid receptors, N-methyl-D-aspartate (NMDA) antagonist activity and the ability to inhibit the reuptake of monoamines has been demonstrated. We hypothesised that, with these properties', methadone might be a good option for the treatment of neuropathic pain in patients with cervical cancer.</p><p><strong>Material and methods: </strong>Patients with cervical cancer stages ll-lll were enrolled in this randomized controlled trial. A comparison was made between methadone versus immediate release morphine (IR morphine), with increasing doses until pain was controlled. Inclusion-period was from October 3<sup>rd</sup> to December 31<sup>st</sup> 2020, and the total patient-study period was 12 weeks. Pain intensity was assessed according to the Numeric Rating Scale (NRS) and Douleur Neuropathique (DN4). The primary objective was to determine whether methadone was clinically superior versus noninferior to morphine as an analgesic for the treatment of cancer related neuropathic pain in women with cervical cancer.</p><p><strong>Results: </strong>A total of 85 women were included; five withdrew and six died during the study period, leaving 74 patients completing the study. All participants showed a reduction in mean values of NRS and DN4 from the time of inclusion and to the end of the study period, for IR morphine and methadone 8.4-2.7 and 8.6-1.5, respectively (<i>P</i> < 0.001). The DN4 score mean reduction for Morphine and Methadone were 6.12-1.37 and 6.05-0, respectively (<i>P</i> < 0.001). Side effects were more common in the group of patients receiving IR morphine compared to the patients treated with methadone.</p><p><strong>Conclusion: </strong>We found that Methadone had a superior analgesic effect with good overall tolerability compared with morphine as a first-line strong opioid for the management of cancer-related neuropathic pain.</p>","PeriodicalId":13319,"journal":{"name":"Indian Journal of Palliative Care","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f5/e7/IJPC-29-200.PMC10261940.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9648148","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Loneliness - Cancer of the Mind. 孤独-心灵的癌症。
IF 1.1 Q3 Medicine Pub Date : 2023-04-01 Epub Date: 2023-05-30 DOI: 10.25259/IJPC_200_2022
Dominic Gerard Benjamin, Priyasha Gummanur

World is greying as the proportion of the ageing population increases and the demography is changing both in the developing and developed world. Contact between people is the central part of everyone's life and the glue that holds communities and society together. Lack of social relations is considered to cause loneliness and isolation for the individual and, simultaneously, on a societal level, leads to marginalisation, social disintegration and diminishing trust between people. This has come to sharp focus during the corona pandemic. Meaningful social connections are central to the physical and mental health of human beings. Off late, the deleterious health implication of social isolation and loneliness has increasingly been noticed, with a higher risk of premature death and accelerated risks of coronary heart disease, stroke, depression, and dementia. Worldwide, there is an increasing awareness regarding the alarming consequences of loneliness, especially among older adults. In response, 2018 saw the launch of a UK loneliness strategy and the first minister for loneliness in the world appointed.

随着老龄化人口比例的增加,世界正在变灰,发展中国家和发达国家的人口结构也在发生变化。人与人之间的联系是每个人生活的核心部分,也是维系社区和社会的粘合剂。缺乏社会关系被认为会导致个人的孤独和孤立,同时,在社会层面上,会导致边缘化、社会解体和人与人之间的信任减少。在新冠疫情期间,这一点成为人们关注的焦点。有意义的社会联系是人类身心健康的核心。社交孤立和孤独对健康的有害影响越来越受到关注,过早死亡的风险更高,冠心病、中风、抑郁症和痴呆症的风险也更高。在世界范围内,人们越来越意识到孤独的可怕后果,尤其是在老年人中。作为回应,2018年,英国启动了一项孤独战略,并任命了世界上第一位孤独部长。
{"title":"Loneliness - Cancer of the Mind.","authors":"Dominic Gerard Benjamin,&nbsp;Priyasha Gummanur","doi":"10.25259/IJPC_200_2022","DOIUrl":"10.25259/IJPC_200_2022","url":null,"abstract":"<p><p>World is greying as the proportion of the ageing population increases and the demography is changing both in the developing and developed world. Contact between people is the central part of everyone's life and the glue that holds communities and society together. Lack of social relations is considered to cause loneliness and isolation for the individual and, simultaneously, on a societal level, leads to marginalisation, social disintegration and diminishing trust between people. This has come to sharp focus during the corona pandemic. Meaningful social connections are central to the physical and mental health of human beings. Off late, the deleterious health implication of social isolation and loneliness has increasingly been noticed, with a higher risk of premature death and accelerated risks of coronary heart disease, stroke, depression, and dementia. Worldwide, there is an increasing awareness regarding the alarming consequences of loneliness, especially among older adults. In response, 2018 saw the launch of a UK loneliness strategy and the first minister for loneliness in the world appointed.</p>","PeriodicalId":13319,"journal":{"name":"Indian Journal of Palliative Care","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2c/ef/IJPC-29-212.PMC10261937.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9648151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Attributes of Psychosocial Distress from the Perspectives of Head-and-Neck Cancer Patients - A Thematic Analysis. 从癌症头颈部患者的角度看心理社会痛苦的属性——主题分析。
IF 1.1 Q3 Medicine Pub Date : 2023-04-01 Epub Date: 2023-01-11 DOI: 10.25259/IJPC_185_2022
Shalini Ganesh Nayak, Krishna Sharan, Anice George

Objectives: Patients diagnosed with head-and-neck cancer (HNC) face unique challenges in comparison to other types of cancers. Sources of psychosocial distress (PSD) are multifactorial and recognising the key attributes would facilitate better understanding of the experienced distress, potentially enabling directed intervention strategies. The present research was conducted to explore the key attributes of PSD from HNC patients' perspective to develop a tool.

Material and methods: The study adopted a qualitative approach. The data were collected from nine HNC patients receiving radiotherapy through focus group discussion. Data were transcribed, read and reread through for searching the meanings and patterns, to familiarise with the data and obtain ideas on experiences related to PSD. Similar experiences identified across the dataset were sorted and then collated into themes. Detailed analysis of themes and related quotes of the participants are reported with each theme.

Results: The codes generated from the study are grouped under four major themes; 'Irksome symptoms are distressing,' 'Distressing physical disability inflicted by the situation,' 'Social Curiosity - a distressing element' and 'Distressing uncertainty of future'. The attributes of PSD and the magnitude of psychosocial problems were reflected in the findings.

Conclusion: Psychosocial health of HNC patients is greatly impacted due to disease and/or treatment. Dynamic patterns of attributes identified from the study contributed to developing a tool on PSD. The findings of this study also necessitate the need for constructing an intervention for reducing PSD based on the attributes from the HNC patient's perspective.

目的:与其他类型的癌症相比,被诊断为癌症(HNC)的患者面临着独特的挑战。心理社会痛苦(PSD)的来源是多因素的,认识到关键特征将有助于更好地理解所经历的痛苦,从而有可能制定有针对性的干预策略。本研究旨在从HNC患者的角度探讨PSD的关键属性,以开发一种工具。材料和方法:研究采用了定性方法。通过焦点小组讨论,收集了9名接受放射治疗的HNC患者的数据。数据被转录、阅读和重读,以搜索含义和模式,熟悉数据并获得与PSD相关的经验。数据集中发现的类似经历被分类,然后整理成主题。每个主题都报告了对主题的详细分析和参与者的相关语录。结果:研究产生的代码分为四个主要主题令人沮丧的症状是令人痛苦的,“这种情况造成的令人痛苦的身体残疾”,“社会好奇心——一种令人痛苦的因素”和“令人痛苦的未来不确定性”。PSD的特点和心理社会问题的严重程度反映在研究结果中。结论:HNC患者的心理社会健康受到疾病和/或治疗的严重影响。研究中确定的属性的动态模式有助于开发PSD工具。这项研究的发现也需要从HNC患者的角度构建一种基于属性的减少PSD的干预措施。
{"title":"Attributes of Psychosocial Distress from the Perspectives of Head-and-Neck Cancer Patients - A Thematic Analysis.","authors":"Shalini Ganesh Nayak,&nbsp;Krishna Sharan,&nbsp;Anice George","doi":"10.25259/IJPC_185_2022","DOIUrl":"10.25259/IJPC_185_2022","url":null,"abstract":"<p><strong>Objectives: </strong>Patients diagnosed with head-and-neck cancer (HNC) face unique challenges in comparison to other types of cancers. Sources of psychosocial distress (PSD) are multifactorial and recognising the key attributes would facilitate better understanding of the experienced distress, potentially enabling directed intervention strategies. The present research was conducted to explore the key attributes of PSD from HNC patients' perspective to develop a tool.</p><p><strong>Material and methods: </strong>The study adopted a qualitative approach. The data were collected from nine HNC patients receiving radiotherapy through focus group discussion. Data were transcribed, read and reread through for searching the meanings and patterns, to familiarise with the data and obtain ideas on experiences related to PSD. Similar experiences identified across the dataset were sorted and then collated into themes. Detailed analysis of themes and related quotes of the participants are reported with each theme.</p><p><strong>Results: </strong>The codes generated from the study are grouped under four major themes; 'Irksome symptoms are distressing,' 'Distressing physical disability inflicted by the situation,' 'Social Curiosity - a distressing element' and 'Distressing uncertainty of future'. The attributes of PSD and the magnitude of psychosocial problems were reflected in the findings.</p><p><strong>Conclusion: </strong>Psychosocial health of HNC patients is greatly impacted due to disease and/or treatment. Dynamic patterns of attributes identified from the study contributed to developing a tool on PSD. The findings of this study also necessitate the need for constructing an intervention for reducing PSD based on the attributes from the HNC patient's perspective.</p>","PeriodicalId":13319,"journal":{"name":"Indian Journal of Palliative Care","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/2e/8a/IJPC-29-181.PMC10261933.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9656528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Lived Experience of Adult Female Cancer Survivors to Discover Common Protective Resilience Factors to Cope with Cancer Experience and to Identify Potential Barriers to Resilience. 成年女性癌症幸存者的生活经验,以发现常见的保护性恢复力因素,应对癌症经验,并确定恢复力的潜在障碍。
IF 1.1 Q3 Medicine Pub Date : 2023-04-01 Epub Date: 2023-01-18 DOI: 10.25259/IJPC_214_2022
Mary Walton, Premila Lee

Objectives: Primary objective - Phase I: The primary objective of this study was as follows: (1) To identify common protective resilient factors that enabled the adult female cancer survivors to cope with the cancer experience. (2) To identify potential barriers to the resilience of adult female cancer survivors. Secondary objective - Phase II: The secondary objective of this study was to develop and validate a resilience tool for cancer survivorship.

Material and methods: A mixed approach using sequential exploratory design was used in the study. A qualitative approach using phenomenology design was used in the first phase followed by a quantitative approach in the second phase. In the first phase, in-depth interviews were conducted until data saturation with 14 female breast cancer survivors chosen by purposive and maximum variation sampling methods based on inclusion criteria. The researcher used Colaizzi's data analysis framework to analyse the transcripts. Findings were configured as protective resilience factors and barriers to resilience. Based on the analysis of the qualitative phase, the researcher developed a 35-item resilience tool for cancer survivorship. Content validity, criterion validity and reliability of the newly developed instrument were assessed.

Results: In the qualitative phase, the mean age of the participants was 57.07 years and the mean age at diagnosis was 55.5 years. The majority 11 (78.57%) of them were homemakers. All 14 (100%) of them had undergone surgery. The majority 11 (78.57%) of them had all three modes of therapy, that is, surgery, chemotherapy and radiation therapy. The categories of themes identified are presented under two main headings, that is, protective resilience factors and barriers to resilience. The theme categories identified under protective resilience factors were personal, social, spiritual, physical, economic and psychological factors. The barriers to resilience identified were lack of awareness, medical/biological barriers, social, financial and psychological barriers. The developed resilience tool had a content validity index of 0.98, a criterion validity of 0.67, internal consistency of 0.88 and stability of 0.99 at a 95% confidence interval. Principle component analysis (PCA) was used to validate the domains. PCA of protective resilience factors (Q1-Q23) and barriers to resilience (Q24-Q35) had Eigenvalues of 7.65 and 4.49, respectively. The resilience tool for cancer survivorship was found to have good construct validity.

Conclusion: The present study has identified the protective resilience factors and barriers to resilience among adult female cancer survivors. The developed resilience tool for cancer survivorship was found to have good validity and reliability. It will be useful for nurses and all other healthcare professionals to assess the resilience needs of cancer survivors and to provide need-b

目的:主要目的-第一阶段:本研究的主要目的如下:(1)确定使成年女性癌症幸存者能够应对癌症经历的常见保护性弹性因素。(2) 确定成年女性癌症幸存者恢复力的潜在障碍。次要目标-第二阶段:本研究的次要目标是开发和验证癌症生存的恢复力工具。材料和方法:本研究采用顺序探索设计的混合方法。第一阶段采用现象学设计的定性方法,第二阶段采用定量方法。在第一阶段,对14名癌症女性幸存者进行了深入访谈,直到数据饱和,这些幸存者是根据纳入标准通过有目的和最大变异的抽样方法选择的。研究人员使用Colaizzi的数据分析框架来分析转录本。研究结果被配置为保护性恢复力因素和恢复力障碍。在定性阶段分析的基础上,研究人员开发了一个35项癌症生存恢复力工具。评估了新开发的工具的内容有效性、标准有效性和可靠性。结果:在定性阶段,参与者的平均年龄为57.07岁,平均诊断年龄为55.5岁。其中11人(78.57%)是家庭主妇。全部14人(100%)接受了手术。其中绝大多数11人(78.57%)接受了手术、化疗和放疗这三种治疗方式。确定的主题类别分为两个主要标题,即保护性复原力因素和复原力障碍。在保护性复原力因素下确定的主题类别是个人、社会、精神、身体、经济和心理因素。确定的恢复力障碍包括缺乏认识、医疗/生物障碍、社会、经济和心理障碍。开发的弹性工具在95%置信区间下的内容有效性指数为0.98,标准有效性为0.67,内部一致性为0.88,稳定性为0.99。主成分分析(PCA)用于验证领域。保护性弹性因子(Q1-Q23)和弹性障碍(Q24-Q35)的PCA特征值分别为7.65和4.49。癌症生存率的弹性工具被发现具有良好的结构有效性。结论:本研究确定了成年女性癌症幸存者的保护性恢复力因素和恢复力障碍。开发的癌症生存恢复力工具具有良好的有效性和可靠性。这将有助于护士和所有其他医疗保健专业人员评估癌症幸存者的复原能力需求,并提供基于需求的优质癌症护理。
{"title":"Lived Experience of Adult Female Cancer Survivors to Discover Common Protective Resilience Factors to Cope with Cancer Experience and to Identify Potential Barriers to Resilience.","authors":"Mary Walton,&nbsp;Premila Lee","doi":"10.25259/IJPC_214_2022","DOIUrl":"10.25259/IJPC_214_2022","url":null,"abstract":"<p><strong>Objectives: </strong>Primary objective - Phase I: The primary objective of this study was as follows: (1) To identify common protective resilient factors that enabled the adult female cancer survivors to cope with the cancer experience. (2) To identify potential barriers to the resilience of adult female cancer survivors. Secondary objective - Phase II: The secondary objective of this study was to develop and validate a resilience tool for cancer survivorship.</p><p><strong>Material and methods: </strong>A mixed approach using sequential exploratory design was used in the study. A qualitative approach using phenomenology design was used in the first phase followed by a quantitative approach in the second phase. In the first phase, in-depth interviews were conducted until data saturation with 14 female breast cancer survivors chosen by purposive and maximum variation sampling methods based on inclusion criteria. The researcher used Colaizzi's data analysis framework to analyse the transcripts. Findings were configured as protective resilience factors and barriers to resilience. Based on the analysis of the qualitative phase, the researcher developed a 35-item resilience tool for cancer survivorship. Content validity, criterion validity and reliability of the newly developed instrument were assessed.</p><p><strong>Results: </strong>In the qualitative phase, the mean age of the participants was 57.07 years and the mean age at diagnosis was 55.5 years. The majority 11 (78.57%) of them were homemakers. All 14 (100%) of them had undergone surgery. The majority 11 (78.57%) of them had all three modes of therapy, that is, surgery, chemotherapy and radiation therapy. The categories of themes identified are presented under two main headings, that is, protective resilience factors and barriers to resilience. The theme categories identified under protective resilience factors were personal, social, spiritual, physical, economic and psychological factors. The barriers to resilience identified were lack of awareness, medical/biological barriers, social, financial and psychological barriers. The developed resilience tool had a content validity index of 0.98, a criterion validity of 0.67, internal consistency of 0.88 and stability of 0.99 at a 95% confidence interval. Principle component analysis (PCA) was used to validate the domains. PCA of protective resilience factors (Q1-Q23) and barriers to resilience (Q24-Q35) had Eigenvalues of 7.65 and 4.49, respectively. The resilience tool for cancer survivorship was found to have good construct validity.</p><p><strong>Conclusion: </strong>The present study has identified the protective resilience factors and barriers to resilience among adult female cancer survivors. The developed resilience tool for cancer survivorship was found to have good validity and reliability. It will be useful for nurses and all other healthcare professionals to assess the resilience needs of cancer survivors and to provide need-b","PeriodicalId":13319,"journal":{"name":"Indian Journal of Palliative Care","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/5b/3a/IJPC-29-186.PMC10261931.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9656529","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Non-Invasive Objective Markers to Measure Pain: A Direction to Develop a Pain Device - A Narrative Review. 测量疼痛的非侵入性客观标记物:开发疼痛设备的方向——叙述性综述。
IF 1.1 Q3 Medicine Pub Date : 2023-04-01 Epub Date: 2023-05-30 DOI: 10.25259/IJPC_257_2022
Varun Shekhar, Nandan Choudhary, Puneet Rathore, Suraj Pal Singh, Sushma Bhatnagar

Objective: To review the literature regarding non-invasive objective measurements of pain. Measuring pain is of uttermost importance, but it can be an inconvenient task, especially in terms of the interpretation of patient's information. Reiterating, there is no "standard" that provides the physician with a method to objectively quantify this problem of patient's pain. For assessing the pain, physician relies solely on unidimensional assessment tools or questionnaire-based pain assessment. Although pain is a subjective experience of the patient, but there is a need to measure pain sometimes in the individuals who cannot communicate their quality and severity of pain.

Material and methods: The articles from PubMed and Google Scholar without any year and age limit were searched in the current narrative review. A total of 16 markers were searched and their relation to pain was studied.

Results: Studies have shown that these markers change in relation to pain and it can be considered a valuable tool for pain measurement but there are multiple factors like psychological and emotional factors which affect these markers.

Conclusion: There is lack of evidence to show which marker can be used for measuring pain accurately. This narrative review is an attempt to look into the various pain-related markers that can be used and it calls for further studies including clinical trials with different diseases and taking into accounts different factors affecting pain to give an accurate measurement of pain.

目的:回顾关于疼痛的非侵入性客观测量的文献。测量疼痛是最重要的,但这可能是一项不方便的任务,尤其是在解释患者信息方面。重申,没有“标准”为医生提供客观量化患者疼痛问题的方法。为了评估疼痛,医生只依赖于一维评估工具或基于问卷的疼痛评估。虽然疼痛是患者的主观体验,但有时有必要测量那些无法交流疼痛质量和严重程度的人的疼痛。材料和方法:在当前的叙述性综述中搜索PubMed和Google Scholar的文章,没有任何年份和年龄限制。共检索了16个标志物,并研究了它们与疼痛的关系。结果:研究表明,这些标志物与疼痛有关,它可以被认为是一种有价值的疼痛测量工具,但有多种因素影响这些标志物,如心理和情绪因素。结论:目前尚无证据表明哪种标记物可以准确测量疼痛。这篇叙述性综述试图研究可以使用的各种疼痛相关标志物,它呼吁进行进一步的研究,包括对不同疾病的临床试验,并考虑影响疼痛的不同因素,以准确测量疼痛。
{"title":"Non-Invasive Objective Markers to Measure Pain: A Direction to Develop a Pain Device - A Narrative Review.","authors":"Varun Shekhar,&nbsp;Nandan Choudhary,&nbsp;Puneet Rathore,&nbsp;Suraj Pal Singh,&nbsp;Sushma Bhatnagar","doi":"10.25259/IJPC_257_2022","DOIUrl":"10.25259/IJPC_257_2022","url":null,"abstract":"<p><strong>Objective: </strong>To review the literature regarding non-invasive objective measurements of pain. Measuring pain is of uttermost importance, but it can be an inconvenient task, especially in terms of the interpretation of patient's information. Reiterating, there is no \"standard\" that provides the physician with a method to objectively quantify this problem of patient's pain. For assessing the pain, physician relies solely on unidimensional assessment tools or questionnaire-based pain assessment. Although pain is a subjective experience of the patient, but there is a need to measure pain sometimes in the individuals who cannot communicate their quality and severity of pain.</p><p><strong>Material and methods: </strong>The articles from PubMed and Google Scholar without any year and age limit were searched in the current narrative review. A total of 16 markers were searched and their relation to pain was studied.</p><p><strong>Results: </strong>Studies have shown that these markers change in relation to pain and it can be considered a valuable tool for pain measurement but there are multiple factors like psychological and emotional factors which affect these markers.</p><p><strong>Conclusion: </strong>There is lack of evidence to show which marker can be used for measuring pain accurately. This narrative review is an attempt to look into the various pain-related markers that can be used and it calls for further studies including clinical trials with different diseases and taking into accounts different factors affecting pain to give an accurate measurement of pain.</p>","PeriodicalId":13319,"journal":{"name":"Indian Journal of Palliative Care","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/0e/ea/IJPC-29-217.PMC10261936.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9648153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nurses' Perceptions Regarding End-of-life Care for Individuals with Non-cancer Diseases on Non-invasive Positive Pressure Ventilation-dependent: A Qualitative and Descriptive Study. 护士对非癌症患者临终关怀的非侵入性正压通气依赖性认知:一项定性和描述性研究。
IF 1.1 Q3 Medicine Pub Date : 2023-04-01 Epub Date: 2023-01-11 DOI: 10.25259/IJPC_184_2022
Mitsuko Ushikubo

Objectives: Palliative care is essential for patients requiring respiratory assistance through non-invasive positive pressure ventilation (NPPV). This study aimed to describe nurses' perception of individuals with NPPV and non-cancer terminal diseases in various clinical settings.

Material and methods: This qualitative and descriptive study was conducted using semi-structured interviews with audio recordings with advanced practice nurses from different clinical settings and obtained their perceptions of end-of-life care for patients with NPPV.

Results: Five categories of nurses' perceptions were extracted: Difficulty with an uncertain prognosis, differences in symptom management by type of disease, benefits and weaknesses of NPPV on palliative care, influence of physicians' attitude toward palliative care and the nature of the medical institutions and influence of patient's age in palliative care.

Conclusion: The nurses' perceptions showed differences and similarities across disease types. There is a need for skills improvement regardless of disease type to minimise the side effects of NPPV. Advanced care planning based on disease-specific characteristics and age-appropriate support and integration of palliative care into acute care is needed for terminal NPPV-dependent patients. Interdisciplinary efforts, as well as the pursuit of expertise in each field, are needed to provide good palliative and end-of-life care for NPPV users with non-cancer diseases.

目的:对于需要通过无创正压通气(NPPV)进行呼吸辅助的患者,姑息治疗至关重要。本研究旨在描述护士在各种临床环境中对NPPV和非癌症终末期疾病患者的认知。材料和方法:这项定性和描述性研究使用半结构化访谈和录音对来自不同临床环境的高级实践护士进行,并获得他们对NPPV患者临终关怀的看法。结果:提取了五类护士的看法:预后不确定的困难,不同疾病类型的症状管理差异、NPPV在姑息治疗中的优势和劣势、医生对姑息治疗的态度和医疗机构性质的影响以及患者年龄对姑息护理的影响。结论:不同疾病类型护士的认知存在差异和相似性。无论疾病类型如何,都需要提高技能,以最大限度地减少NPPV的副作用。晚期NPPV依赖患者需要基于疾病特异性特征和适龄支持的高级护理规划,并将姑息治疗纳入急性护理。需要跨学科的努力,以及在每个领域寻求专业知识,为患有非癌症疾病的NPPV用户提供良好的姑息治疗和临终关怀。
{"title":"Nurses' Perceptions Regarding End-of-life Care for Individuals with Non-cancer Diseases on Non-invasive Positive Pressure Ventilation-dependent: A Qualitative and Descriptive Study.","authors":"Mitsuko Ushikubo","doi":"10.25259/IJPC_184_2022","DOIUrl":"10.25259/IJPC_184_2022","url":null,"abstract":"<p><strong>Objectives: </strong>Palliative care is essential for patients requiring respiratory assistance through non-invasive positive pressure ventilation (NPPV). This study aimed to describe nurses' perception of individuals with NPPV and non-cancer terminal diseases in various clinical settings.</p><p><strong>Material and methods: </strong>This qualitative and descriptive study was conducted using semi-structured interviews with audio recordings with advanced practice nurses from different clinical settings and obtained their perceptions of end-of-life care for patients with NPPV.</p><p><strong>Results: </strong>Five categories of nurses' perceptions were extracted: Difficulty with an uncertain prognosis, differences in symptom management by type of disease, benefits and weaknesses of NPPV on palliative care, influence of physicians' attitude toward palliative care and the nature of the medical institutions and influence of patient's age in palliative care.</p><p><strong>Conclusion: </strong>The nurses' perceptions showed differences and similarities across disease types. There is a need for skills improvement regardless of disease type to minimise the side effects of NPPV. Advanced care planning based on disease-specific characteristics and age-appropriate support and integration of palliative care into acute care is needed for terminal NPPV-dependent patients. Interdisciplinary efforts, as well as the pursuit of expertise in each field, are needed to provide good palliative and end-of-life care for NPPV users with non-cancer diseases.</p>","PeriodicalId":13319,"journal":{"name":"Indian Journal of Palliative Care","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/fa/93/IJPC-29-175.PMC10261932.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9654499","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Kannada Translation and Validation of the ESAS-r Renal for Symptom Burden Survey in Patients with End-Stage Kidney Disease. ESAS-r肾脏用于终末期肾病患者症状负担调查的卡纳达语翻译和验证。
IF 1.1 Q3 Medicine Pub Date : 2023-04-01 Epub Date: 2023-05-30 DOI: 10.25259/IJPC_216_2022
Bharathi Naik, Shankar Prasad Nagaraju, Vasudeva Guddattu, Naveen Salins, Ravindra Prabhu, Anuja Damani, Prathvi Naik, Krithika S Rao, Indu Ramachandra Rao, Pankaj Singhai

Objectives: End-stage kidney disease (ESKD) is a life-limiting illness that leads to significant health-related suffering for the patients and their caregivers. Moreover, disease-directed options such as dialysis and renal transplant might not be universally accessible. Inadequate assessment and management of symptoms often lead to diminished quality of life. For evaluating symptoms and their associated distress, various tools have been identified. However, these are not available for the native Kannada-speaking population for assessing ESKD symptom burden. In this study, we determined the reliability and validity of the Edmonton Symptom Assessment System Revised Renal (ESAS-r: Renal) in Kannada-speaking ESKD patients.

Materials and methods: ESAS-r: Renal English version was translated into Kannada using the forward and backward method. The translated version was endorsed by Nephrology, Palliative care, Dialysis technology and Nursing experts. As a pilot study, 12 ESKD patients evaluated the content of the questionnaires for appropriateness and relevance. The ESAS-r: Renal Kannada version was validated by administering this tool to 45 patients twice a fortnight.

Result: The translated ESAS-r: Renal Kannada version questionnaire had an acceptable face and content validity. Experts' opinion was assessed by content validity ratio (CVR), and the value of CVR of ESAS-r: Renal Kannada version was-'1'-. Internal consistency of the tool was assessed among Kannada-speaking ESKD patients; its Cronbach's α was 0.785, and test-retest validity was 0.896.

Conclusion: The validated Kannada version of ESAS-r: Renal was reliable and valid for assessing symptom burden in ESKD patients.

目的:终末期肾病(ESKD)是一种限制生命的疾病,会给患者及其护理人员带来严重的健康相关痛苦。此外,以疾病为导向的选择,如透析和肾移植,可能不是普遍可行的。对症状的评估和管理不足往往会导致生活质量下降。为了评估症状及其相关的痛苦,已经确定了各种工具。然而,这些不适用于母语为卡纳达语的人群来评估ESKD症状负担。在这项研究中,我们确定了埃德蒙顿症状评估系统改良肾功能(ESAS-r:肾功能)在卡纳达语ESKD患者中的可靠性和有效性。材料和方法:ESAS-r:Renal英文版采用前后法翻译成卡纳达语。翻译版本得到了肾病学、姑息治疗、透析技术和护理专家的认可。作为一项试点研究,12名ESKD患者评估了问卷内容的适当性和相关性。ESAS-r:肾卡纳达版本通过每两周两次对45名患者使用该工具进行验证。结果:经翻译的ESAS-r:肾卡纳达语版问卷具有可接受的表面和内容有效性。专家的意见通过内容有效性比率(CVR)进行评估,ESAS-r:肾卡纳达语版本的CVR值为-'1'-。在讲卡纳达语的ESKD患者中评估了该工具的内部一致性;其Cronbachα为0.785,重测有效性为0.896。结论:经验证的卡纳达版本的ESAS-r:肾脏在评估ESKD患者的症状负担方面是可靠和有效的。
{"title":"Kannada Translation and Validation of the ESAS-r Renal for Symptom Burden Survey in Patients with End-Stage Kidney Disease.","authors":"Bharathi Naik,&nbsp;Shankar Prasad Nagaraju,&nbsp;Vasudeva Guddattu,&nbsp;Naveen Salins,&nbsp;Ravindra Prabhu,&nbsp;Anuja Damani,&nbsp;Prathvi Naik,&nbsp;Krithika S Rao,&nbsp;Indu Ramachandra Rao,&nbsp;Pankaj Singhai","doi":"10.25259/IJPC_216_2022","DOIUrl":"10.25259/IJPC_216_2022","url":null,"abstract":"<p><strong>Objectives: </strong>End-stage kidney disease (ESKD) is a life-limiting illness that leads to significant health-related suffering for the patients and their caregivers. Moreover, disease-directed options such as dialysis and renal transplant might not be universally accessible. Inadequate assessment and management of symptoms often lead to diminished quality of life. For evaluating symptoms and their associated distress, various tools have been identified. However, these are not available for the native Kannada-speaking population for assessing ESKD symptom burden. In this study, we determined the reliability and validity of the Edmonton Symptom Assessment System Revised Renal (ESAS-r: Renal) in Kannada-speaking ESKD patients.</p><p><strong>Materials and methods: </strong>ESAS-r: Renal English version was translated into Kannada using the forward and backward method. The translated version was endorsed by Nephrology, Palliative care, Dialysis technology and Nursing experts. As a pilot study, 12 ESKD patients evaluated the content of the questionnaires for appropriateness and relevance. The ESAS-r: Renal Kannada version was validated by administering this tool to 45 patients twice a fortnight.</p><p><strong>Result: </strong>The translated ESAS-r: Renal Kannada version questionnaire had an acceptable face and content validity. Experts' opinion was assessed by content validity ratio (CVR), and the value of CVR of ESAS-r: Renal Kannada version was-'1'-. Internal consistency of the tool was assessed among Kannada-speaking ESKD patients; its Cronbach's α was 0.785, and test-retest validity was 0.896.</p><p><strong>Conclusion: </strong>The validated Kannada version of ESAS-r: Renal was reliable and valid for assessing symptom burden in ESKD patients.</p>","PeriodicalId":13319,"journal":{"name":"Indian Journal of Palliative Care","volume":null,"pages":null},"PeriodicalIF":1.1,"publicationDate":"2023-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/35/3b/IJPC-29-195.PMC10261939.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9648150","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Indian Journal of Palliative Care
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1